Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 0.72 |
| ▸ | CA1 | P00915 | 8/20 | 0.72 |
| ▸ | CA2 | P00918 | 8/20 | 0.72 |
| ▸ | CA4 | P22748 | 4/20 | 0.72 |
| ▸ | CA5A | P35218 | 4/20 | 0.72 |
| ▸ | CA7 | P43166 | 4/20 | 0.72 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | PARP1 | P09874 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 4/20 | 0.53 |
| ▸ | P4HB | P07237 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1170779 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL15653572 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL17993793 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL17159594 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL20169037 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL23642758 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL14478515 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL1029421 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL22927973 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A | |
| SCHEMBL15422483 | 1.00 | CA12 (0.72) | CA12CA1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622563-B2 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2009-11-24 | — | — | US | disclosed |
| WO-2007128480-A2 | THIOGLYCOSIDES AS PHARMACEUTICALLY ACTIVE AGENTS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-11-15 | — | — | WO | disclosed |
| US-20050272921-A1 | Process for producing glycoside | MITSUI CHEMICALS, INC. (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1544207-A1 | PROCESS FOR PRODUCING GLYCOSIDE | Mitsui Chemicals, Inc. (JP) | 2005-06-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272921-A1 | Process for producing glycoside | HAAO, OGA, MGAM | CA12 31/4885CA1 206/4885CA2 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.